Table 1 Demographic and clinical characteristics of PC patients and survival using Kaplan–Meier method

Age at diagnosis

≤60 years

56 (13.7)

84 (68-98)

<0.001

61-70 years

150 (36.8)

60 (50-71)

71-80 years

143 (34.6)

46 (37-51.5)

≥81 years

61 (14.9)

30 (22-34.5)

Residence

Rural

128 (31.2)

45 (37-50)

0.022

Urban

282 (68.8)

55 (46-60.5)

Marital status

Single

30 (7.3)

44 (25-64)

0.327

Married

380 (92.7)

49 (45-55.5)

Occupation

Unemployed

107 (26.1)

41 (31.5-50)

0.003

Worker

62 (15.1)

47 (33-70)

Self-employed

207 (50.5)

50 (46-60)

Employee

34 (8.3)

62 (51-74)

Education

Illiterate

141 (34.4)

44 (37-48)

0.002

Diploma or below

242 (59)

55 (46.5-64)

Academic

27 (6.6)

91 (80-102)

Tobacco history

No

286 (69.8)

48 (44-59.5)

0.978

Yes

124 (30.2)

49 (42-56)

Alcohol history

No

399 (97.3)

49 (45-55.5)

0.568

Yes

11 (2.7)

51 (32.5-68)

Family history of PC

No

362 (88.3)

50 (46-56)

0.498

Yes

48 (11.7)

46.5 (30-70.5)

Comorbidity

No

240 (58.5)

55 (48-63)

0.042

Yes

170 (41.5)

45 (37-50)

AJCC stage of disease

I

102 (24.9)

84 (68.5-102)

<0.001

II

114 (27.8)

70 (61.5-91)

III

152 (37.1)

30 (26-35)

IV

42 (10.2)

24 (19-26)

Gleason score

≤ 6

85 (20.7)

102 (91-112)

<0.001

7

94 (22.9)

61 (60-74)

8

114 (27.8)

36.5 (34.5-40)

≥ 9

117 (28.5)

19 (17-22)

Treatment

No treatment

30 (7.3)

31.5 (26-35)

<0.001

Active surveillance

63 (15.4)

109 (90-123)

Radical Prostatectomy

40 (9.8)

102 (87-114)

Radiotherapy

87 (21.2)

58 (51.5-64)

Radiotherapy + Radical Prostatectomy

51 (12.4)

49 (38-67)

Orchiectomy

86 (21)

29 (23-33)

Androgen therapy

53 (12.9)

22 (16-26)